Transarterial Embolization of Intermediate Hepatocellular Carcinoma in Elderly Patients: Which Technique Should Be First-line?

Transarterial Embolization of Intermediate Hepatocellular Carcinoma in Elderly Patients: Which Technique Should Be First-line?

Bibliographic Details
Main Authors:	Azzam Khankan, Abdul Rahman Jazieh
Format:	Article
Language:	English
Published:	Thieme Medical and Scientific Publishers Pvt. Ltd. 2018-01-01
Series:	The Arab Journal of Interventional Radiology
Online Access:	http://www.thieme-connect.de/DOI/DOI?10.4103/AJIR.AJIR_4_18

Similar Items

Transarterial therapy: An evolving treatment modality of hepatocellular carcinoma
by: Khalid A Jazieh, et al.
Published: (2014-01-01)

Cerebral Lipiodol Embolism in Hepatocellular Carcinoma Patients Treated with Transarterial Embolization/Chemoembolization.
by: Hai-Jui Chu, et al.
Published: (2015-01-01)

Transarterial Chemoembolization Combined With Hepatectomy for the Treatment of Intermediate-Stage Hepatocellular Carcinoma
by: Qunfang Zhou, et al.
Published: (2020-11-01)

Combined resection and radiofrequency ablation versus transarterial embolization for intermediate-stage hepatocellular carcinoma: A propensity score matching study
by: Wendell Espinosa, et al.
Published: (2018-03-01)

Transarterial Chemoembolization of Hepatocellular Carcinoma with Idarubicin-Loaded Tandem Drug-Eluting Embolics
by: Boris Guiu, et al.
Published: (2019-07-01)

Partial Splenic Embolization with Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma Accompanied by Thrombocytopenia
by: Yoshihiko Ooka, et al.
Published: (2014-01-01)

Transarterial Embolization for Hepatocellular Carcinoma: A Comparison between Nonspherical PVA and Microspheres
by: Leandro Armani Scaffaro, et al.
Published: (2015-01-01)

Comparison of surgical resection and transarterial chemoembolization for patients with intermediate stage hepatocellular carcinoma
by: Chih-Lin Lin, et al.
Published: (2016-06-01)

Transarterial chemoembolization versus resection for intermediate-stage (BCLC B) hepatocellular carcinoma
by: Jun Young Kim, et al.
Published: (2016-06-01)

Liver resection versus transarterial chemoembolization for the treatment of intermediate‐stage hepatocellular carcinoma
by: Shuling Chen, et al.
Published: (2019-04-01)

Survival analysis of 230 patients with unresectable hepatocellular carcinoma treated with bland transarterial embolization.
by: Ezio Lanza, et al.
Published: (2020-01-01)

Cured giant hepatocellular carcinoma after transarterial embolization complicated with liver abscess formation
by: Malkhaz Mizandari, MD,PhD, et al.
Published: (2020-09-01)

Transarterial embolization for hepatocellular adenomas: Case report and literature review
by: Jian-Hong Zhong, et al.
Published: (2018-01-01)

A prognostic score for patients with intermediate-stage hepatocellular carcinoma treated with transarterial chemoembolization.
by: Sadahisa Ogasawara, et al.
Published: (2015-01-01)

Sarcopenia as a predictor of survival in patients undergoing bland transarterial embolization for unresectable hepatocellular carcinoma.
by: Ezio Lanza, et al.
Published: (2020-01-01)

Tumor lysis syndrome after transarterial chemoembolization plus portal venous embolization for hepatocellular carcinoma
by: Wan-Ling Tsai, et al.
Published: (2012-12-01)

Transarterial Chemoembolization Combined with Radiofrequency Ablation in the Treatment of Stage B1 Intermediate Hepatocellular Carcinoma
by: Furong Liu, et al.
Published: (2019-01-01)

Prognostic factors analysis for patient with BCLC intermediate stage hepatocellular carcinoma following transarterial chemoembolization
by: Chieh- Ling Yen, et al.
Published: (2015)

Transarterial chemoembolisation in intermediate-stage hepatocellular carcinoma. Survey on clinical practice in hospitals in the Madrid Region
by: Ana Matilla Peña, et al.
Published: (2015-03-01)

Correction: Sarcopenia as a predictor of survival in patients undergoing bland transarterial embolization for unresectable hepatocellular carcinoma.
by: Ezio Lanza, et al.
Published: (2020-01-01)

Transarterial chemoembolization combined with iodine 125 seeds versus transarterial chemoembolization combined with radiofrequency ablation in the treatment of early- and intermediate-stage hepatocellular carcinoma
by: Lei Chen, et al.
Published: (2020-06-01)

Analyses of Intermediate-Stage Hepatocellular Carcinoma Patients Receiving Transarterial Chemoembolization prior to Designing Clinical Trials
by: Keisuke Koroki, et al.
Published: (2020-07-01)

Effect of Transarterial Chemoembolization on ALBI Grade in Intermediate-Stage Hepatocellular Carcinoma: Criteria for Unsuitable Cases Selection
by: Chen-Ta Chi, et al.
Published: (2021-08-01)

Treatment Strategy of Transarterial Chemoembolization for Hepatocellular Carcinoma
by: Shiro Miyayama
Published: (2020-10-01)

Recent Updates of Transarterial Chemoembolilzation in Hepatocellular Carcinoma
by: Young Chang, et al.
Published: (2020-10-01)

Transarterial radioembolization for hepatocellular carcinoma: a review
by: Sacco R, et al.
Published: (2016-07-01)

Spontaneously Ruptured Hepatocellular Carcinoma Treated by Transarterial Embolization Compared with Conservative Treatment: Survival Outcome and Prognostic Factors
by: Walailak Chaiyasoot, et al.
Published: (2021-06-01)

The efficacy and safety of postoperative adjuvant transarterial embolization and radiotherapy in hepatocellular carcinoma patients with portal vein tumor thrombus
by: Bai T, et al.
Published: (2016-06-01)

Safety margin of embolized area can reduce local recurrence of hepatocellular carcinoma after superselective transarterial chemoembolization
by: Kittipitch Bannangkoon, et al.
Published: (2019-03-01)

Early- and intermediate-term outcome of transarterial embolization for symptomatic hepatic focal nodular hyperplasia
by: Guodong Zhang, et al.
Published: (2018-05-01)

Transarterial RAdioembolization versus ChemoEmbolization for the treatment of hepatocellular carcinoma (TRACE): study protocol for a randomized controlled trial
by: Seinstra Beatrijs A, et al.
Published: (2012-08-01)

Outcome of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma
by: Hadeel A Helmi, et al.
Published: (2020-01-01)

Evaluation of transarterial chemoembolization refractoriness in patients with hepatocellular carcinoma.
by: Jonggi Choi, et al.
Published: (2020-01-01)

Transarterial chemoembolization for hepatocellular carcinoma in Fontan surgery patient
by: Antonio Orlacchio, M.D., et al.
Published: (2020-12-01)

Transarterial chemoembolization for hepatocellular carcinoma with drug-eluting microspheres
by: Waleed M. Hetta, et al.
Published: (2014-09-01)

Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma: Predictors of Survival
by: Summit Sawhney, et al.
Published: (2011-01-01)

Recent advances in transarterial embolotherapies in the treatment of hepatocellular carcinoma
by: Edward Wolfgang Lee, et al.
Published: (2017-12-01)

Healthcare costs of transarterial chemoembolization in the treatment of hepatocellular carcinoma
by: Fateen W, et al.
Published: (2017-10-01)

Transarterial chemoembolization for the treatment of hepatocellular carcinoma: a review
by: Sacco R, et al.
Published: (2017-07-01)

Tumor Marker-Based Definition of the Transarterial Chemoembolization-Refractoriness in Intermediate-Stage Hepatocellular Carcinoma: A Multi-Cohort Study
by: Jun Sik Yoon, et al.
Published: (2019-11-01)